Neuroscience News Extended courses of Paxlovid may alleviate symptoms in some patients with long Covid, though its effectiveness varies widely. Of 13 patients studied, five experienced sustained improvements, while others reported temporary or no benefits.
This complexity underscores the challenge of treating long Covid, a condition with over 200 symptoms ranging from brain fog to respiratory issues. Researchers emphasize the need for more targeted studies to determine which patients might benefit most from antiviral therapies.